Forge Biologics

Forge Biologics company information, Employees & Contact Information

Explore related pages

Related company profiles:

Forge, a member of Ajinomoto Bio-Pharma Services, is a gene therapy development engine, focused on enabling access to life changing gene therapies and helping bring them from idea into reality. We partner with innovators in the gene therapy community: scientists, physicians, biotech/pharma companies, and patient groups. We bring expertise in gene therapy manufacturing and therapeutics development to the table, helping champion teams that are navigating the long road from the lab bench to the bedside. With a patients-first approach, we are forging new models for working together to better accelerate these transformative medicines to reach those who need them most.

Company Details

Employees
399
Founded
-
Address
Columbus, Ohio, Us
Email
he****@****ics.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Columbus, Ohio
Looking for a particular Forge Biologics employee's phone or email?

Forge Biologics Questions

News

Avista Therapeutics and Forge Biologics Announce AAV Development and cGMP Manufacturing Partnership - Business Wire

Avista Therapeutics and Forge Biologics Announce AAV Development and cGMP Manufacturing Partnership Business Wire

Forge Biologics Announces AAV Development and cGMP Manufacturing Relationship with Fractyl Health to Advance Their Gene Therapy Platform for Patients with Metabolic Diseases - Business Wire

Forge Biologics Announces AAV Development and cGMP Manufacturing Relationship with Fractyl Health to Advance Their Gene Therapy Platform for Patients with Metabolic Diseases Business Wire

Affinia Therapeutics and Forge Biologics Announce AAV cGMP Manufacturing Partnership to Advance Affinia Therapeutics' Pipeline of Next-Generation Gene Therapies to the Clinic - PR Newswire

Affinia Therapeutics and Forge Biologics Announce AAV cGMP Manufacturing Partnership to Advance Affinia Therapeutics' Pipeline of Next-Generation Gene Therapies to the Clinic PR Newswire

Design It Right: Evaluating AAV Manufacturability Through Molecular and Upstream Optimization - Endpoints News

Design It Right: Evaluating AAV Manufacturability Through Molecular and Upstream Optimization Endpoints News

Forge Biologics Summer Internship Program | CBC Undergraduate Program - U.OSU

Forge Biologics Summer Internship Program | CBC Undergraduate Program U.OSU

MDA Kickstart Program Receives FDA Rare Pediatric Disease Designation and Orphan Drug Designation for Congenital Myasthenic Syndrome - Muscular Dystrophy Association

MDA Kickstart Program Receives FDA Rare Pediatric Disease Designation and Orphan Drug Designation for Congenital Myasthenic Syndrome Muscular Dystrophy Association

Forge Biologics Names New CEO - Contract Pharma

Forge Biologics Names New CEO Contract Pharma

Genesis Of A Gene Therapy Manufacturing Giant - Bioprocess Online

Genesis Of A Gene Therapy Manufacturing Giant Bioprocess Online

MDA Kickstart Program Launches for Ultra-Rare Neuromuscular Disease Drug Development - Muscular Dystrophy Association

MDA Kickstart Program Launches for Ultra-Rare Neuromuscular Disease Drug Development Muscular Dystrophy Association

Comprehensive characterization of plasmid and AAV gene therapy products with Forge Biologics’ hybrid sequencing approach - Endpoints News

Comprehensive characterization of plasmid and AAV gene therapy products with Forge Biologics’ hybrid sequencing approach Endpoints News

Forge Biologics Announces the FUEL™ AAV Manufacturing Platform to Provide Developers with a More Efficient Solution for Gene Therapy Production - Business Wire

Forge Biologics Announces the FUEL™ AAV Manufacturing Platform to Provide Developers with a More Efficient Solution for Gene Therapy Production Business Wire

Forge Biologics Launches FUEL Manufacturing Platform - Contract Pharma

Forge Biologics Launches FUEL Manufacturing Platform Contract Pharma

Ajinomoto Co., Inc. to Acquire Forge Biologics for $620 Million1 - Business Wire

Ajinomoto Co., Inc. to Acquire Forge Biologics for $620 Million1 Business Wire

Forge Biologics Closes $80 Million in Additional Financing to Accelerate Planned CDMO Expansion - Business Wire

Forge Biologics Closes $80 Million in Additional Financing to Accelerate Planned CDMO Expansion Business Wire

Forge Biologics Forms Independent Scientific and Manufacturing Advisory Board with Panel of Gene Therapy Leaders - Business Wire

Forge Biologics Forms Independent Scientific and Manufacturing Advisory Board with Panel of Gene Therapy Leaders Business Wire

Forge Biologics Announces Updated Positive Clinical Data in RESKUE, a Novel Phase 1/2 Gene Therapy Trial for Patients with Krabbe Disease - Business Wire

Forge Biologics Announces Updated Positive Clinical Data in RESKUE, a Novel Phase 1/2 Gene Therapy Trial for Patients with Krabbe Disease Business Wire

Myrtelle and Forge Biologics Announce Viral Vector and Plasmid DNA cGMP Manufacturing Partnership - Business Wire

Myrtelle and Forge Biologics Announce Viral Vector and Plasmid DNA cGMP Manufacturing Partnership Business Wire

Forge Biologics Expands Gene Therapy Leadership Team with Appointment of John Maslowski as Chief Commercial Officer - Business Wire

Forge Biologics Expands Gene Therapy Leadership Team with Appointment of John Maslowski as Chief Commercial Officer Business Wire

Solid Biosciences and Forge Biologics Announce Viral Vector Contract Development and cGMP Manufacturing Partnership - Business Wire

Solid Biosciences and Forge Biologics Announce Viral Vector Contract Development and cGMP Manufacturing Partnership Business Wire

GentiBio and Forge Biologics Announce Viral Vector Contract Development and GMP Manufacturing Partnership - Business Wire

GentiBio and Forge Biologics Announce Viral Vector Contract Development and GMP Manufacturing Partnership Business Wire

3 Tiers for AAV Potency Assay Development Success - Endpoints News

3 Tiers for AAV Potency Assay Development Success Endpoints News

Forge Biologics Summer Internships | CBC Undergraduate Program - U.OSU

Forge Biologics Summer Internships | CBC Undergraduate Program U.OSU

Final co-founder leaving Forge Biologics following its acquisition - The Business Journals

Final co-founder leaving Forge Biologics following its acquisition The Business Journals

Central Ohio's Coolest Offices: Forge Biologics keeps growing in Grove City - The Business Journals

Central Ohio's Coolest Offices: Forge Biologics keeps growing in Grove City The Business Journals

Forge Biologics to be acquired for $620 million - The Business Journals

Forge Biologics to be acquired for $620 million The Business Journals

CDMO Ajinomoto forges ahead with Forge Biologics in $620M acquisition - Fierce Pharma

CDMO Ajinomoto forges ahead with Forge Biologics in $620M acquisition Fierce Pharma

Gene therapy company secures largest series B financing in Ohio's history - The Columbus Dispatch

Gene therapy company secures largest series B financing in Ohio's history The Columbus Dispatch

Gene therapy startup Forge Biologics raises $90M on biotech manufacturing strength - The Business Journals

Gene therapy startup Forge Biologics raises $90M on biotech manufacturing strength The Business Journals

Forge Biologics and OBiO Technology Sign Separate Gene Therapy Deals - Genetic Engineering and Biotechnology News

Forge Biologics and OBiO Technology Sign Separate Gene Therapy Deals Genetic Engineering and Biotechnology News

Maria Escolar, MD, on Combining HSCT With Gene Therapy in Krabbe Disease - CGTLive®

Maria Escolar, MD, on Combining HSCT With Gene Therapy in Krabbe Disease CGTLive®

Co-founder departs Forge Biologics after gene therapy startup's acquisition - The Business Journals

Co-founder departs Forge Biologics after gene therapy startup's acquisition The Business Journals

Top Forge Biologics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant